Lung Diseases Cies Search Engine [selected websites]

Loading

Jul 14, 2010

Pulmonx : $32 Million for Launch of Emphysema Products

PulmonxFebruary 22, 2010 - Emerging Interventional Pulmonology Leader Commences Rollout of Breakthrough New ProductsPulmonx, an emerging leader in interventional pulmonology, announced that it has concluded an agreement for a new round of equity financing from an investment syndicate led by two new investors. The company also announced that it plans to use this capital to support the international commercial launch of its Zephyr® Endobronchial Valve (EBV), and its recently approved Chartis® Pulmonary Assessment System. Both products are CE marked and cleared for sale in Europe and other major international markets. The company expects that this round of financing will fund the expansion of its commercial operations through to positive cash flow and profitability... [PDF] Pulmonx's Press Release -